Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Accumulated Expenses: 2017-2018

Historic Accumulated Expenses for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $2.8 million.

  • Astria Therapeutics' Accumulated Expenses fell 9.30% to $2.5 million in Q3 2019 from the same period last year, while for Sep 2019 it was $2.5 million, marking a year-over-year decrease of 9.30%. This contributed to the annual value of $2.8 million for FY2018, which is 13.61% up from last year.
  • Astria Therapeutics' Accumulated Expenses amounted to $2.8 million in FY2018, which was up 13.61% from $2.4 million recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Accumulated Expenses registered a high of $2.8 million during FY2018, and its lowest value of $2.4 million during FY2017.
  • Moreover, its 2-year median value for Accumulated Expenses was $2.6 million (2017), whereas its average is $2.6 million.
  • Data for Astria Therapeutics' Accumulated Expenses shows a peak YoY increased of 13.61% (in 2018) over the last 5 years.
  • Astria Therapeutics' Accumulated Expenses (Yearly) stood at $2.4 million in 2017, then climbed by 13.61% to $2.8 million in 2018.